Literature DB >> 27208655

Evaluation of dry powder inhalers with a focus on ease of use and user preference in inhaler-naïve individuals.

Sofia von Schantz1, Nina Katajavuori2, Osmo Antikainen2, Anne Juppo2.   

Abstract

Inhaler errors are common amongst inhaler users. Therefore, in the development work of new inhalation devices, it is important to characterize the ease of use of the inhalers. In this study four dry powder inhalers, Diskus, Easyhaler, Ellipta and Turbuhaler, were evaluated, focusing on ease of use and patient preference. The study used a triangular methodology. The sample consisted of 31 inhaler naïve individuals. Educational videos for all inhalers were watched, and afterwards, the use of all four inhalers was demonstrated in a random order. The demonstrations were videotaped. Thereafter they were checked against a predefined checklist and all mistakes were recorded. Only 33% of inhaler demonstrations were completed without the participants making any mistakes. The proportions of subjects who used the devices correctly were as follows: Diskus 48%, Easyhaler 19%, Ellipta 55% and Turbuhaler 16%. When comparing correct and incorrect inhaler technique for each inhaler pair the following differences were statistically significant: Diskus vs. Easyhaler (p<0.05), Ellipta vs. Easyhaler (p<0.01), Diskus vs. Turbuhaler (p<0.01), Ellipta vs. Turbuhaler (p<0.01). In the participants' ranking, the inhalers Ellipta, followed by Turbuhaler, were most often ranked as most preferred. Participants' preference of Ellipta over Easyhaler (p<0.01) and over Diskus (p<0.001) were statistically significant.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dry powder inhaler; Ease of use; Inhalation errors; Preference

Mesh:

Substances:

Year:  2016        PMID: 27208655     DOI: 10.1016/j.ijpharm.2016.05.023

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.

Authors:  James Greenwood; Carsten Schwarz; Urte Sommerwerck; Edward F Nash; Michael Tamm; Weihua Cao; Paul Mastoridis; Laurie Debonnett; Kamal Hamed
Journal:  Ther Adv Respir Dis       Date:  2017-07       Impact factor: 4.031

2.  Correct use and ease of use of a placebo dry powder inhaler in subjects with asthma and chronic obstructive pulmonary disease.

Authors:  Gregory J Feldman; Dmitry V Galkin; Pinal Patel; Kathryn A Collison; Raj Sharma
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

Review 3.  What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape.

Authors:  Federico Lavorini; Christer Janson; Fulvio Braido; Georgios Stratelis; Anders Løkke
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

4.  Development and Practical Application of a Multiple-Criteria Decision Analysis Framework on Respiratory Inhalers: Is It Always Useful in the MOH Malaysia Medicines Formulary Listing Context?

Authors:  Yee Vern Yong; Siti Hajar Mahamad Dom; Nurulmaya Ahmad Sa'ad; Rosliza Lajis; Faridah Aryani Md Yusof; Jamalul Azizi Abdul Rahaman
Journal:  MDM Policy Pract       Date:  2021-03-30

5.  Comparison of Two pMDIs in Adult Asthmatics: A Randomized Double-Blind Double-Dummy Clinical Trial.

Authors:  Tae-Hyun Nam; Sung-Yoon Kang; Sang Min Lee; Tae-Bum Kim; Sang Pyo Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2021-11-29

6.  Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences.

Authors:  Henrik Svedsater; Helen A Doll; Jake Macey; Gail Miles; Lisa Bradshaw; Magdalena Vanya
Journal:  Adv Ther       Date:  2018-08-13       Impact factor: 3.845

Review 7.  Identifying Critical Errors: Addressing Inhaler Technique in the Context of Asthma Management.

Authors:  Sinthia Z Bosnic-Anticevich; Biljana Cvetkovski; Elizabeth A Azzi; Pamela Srour; Rachel Tan; Vicky Kritikos
Journal:  Pulm Ther       Date:  2018-04-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.